Turn Therapeutics Inc. Common Stock TTRX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q1 '25 | Q4 '24 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 2.2×+1.4× | 0.9×-0.6× | 1.4×— | —— | 1.6×— | |
| Quick ratio | 2.2×+1.4× | 0.9×-0.6× | 1.4×— | —— | 1.6×— | |
| Cash ratio | 2.2×+1.3× | 0.8×-0.5× | 1.3×— | —— | 1.2×— | |
| Leverage | ||||||
| Debt-to-equity | 1×+1.0× | 0×-0.2× | 0.2×— | —— | —— | |
| Debt-to-assets | 0.3×+0.3× | 0×0.0× | 0×— | —— | 0.1×— | |
| Per Share | ||||||
| Book value per share | $0.21+22.7% | $0.17+839% | $0.02-40.8% | $0.03+554% | -$0.01+56.8% | |
| Valuation | ||||||
| Market capitalization | $217.45M-17.7% | $116.01M— | —— | —— | —— | |
| Enterprise value | $212.24M— | $111.02M— | —— | —— | —— | |
| Price / book | 34.7×— | 24.8×— | —— | —— | —— |
Questions, answered.
- Where do Turn Therapeutics Inc. Common Stock's ratios come from?
- Every ratio is computed from Turn Therapeutics Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.